Categroies

1/1
Number of views:
1000

Dapagliflozin

ARXIGA is a sodium-glucose cotransporter 2 (SGLT2) inhibitor indicated for use as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes.
Retail price
0.0
Market price
0.0
Number of views:
1000
Product serial number
Category
Diabetes
Quantity
-
+
Stock:
0
1
Details
Cas No.:
461432-26-8
Indication:

ARXIGA is a sodium-glucose cotransporter 2 (SGLT2) inhibitor indicated for use as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes.

ARXIGA is a sodium-glucose cotransporter 2 (SGLT2) inhibitor indicated for use as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes.

We could not find any corresponding parameters, please add them to the properties table
Next

keyword:Chemical products,Chinese medicine products

Inquiry

Huafang Pharmceutical Sciences

Hotline:0551-65551391

Fax:0551-65336396

Add: Building D-5, Technology Industrial Park, 168 Xiangzhang Avenue, National High-tech Zone, Hefei City

Huafang

Wechat

Huafang

Mobile

Copyright © Huafang Pharmceutical